ArticleJournal of ophthalmic & vision research

Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy.

Arash Maleki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.